OGI Bio
PrivateLast Round
Strategic
Jul 22, 2025
Total Funding Raised
$2.7M
Momentum Score
50 /100
Company Overview
OGI Bio is a biotechnology company that develops and provides automated bioreactor systems to make growing and analyzing microbes easier and more efficient.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Workflow Automation, Biotechnology, Sensors
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
OGI Bio Comps
Public and private peers based on sector, stage, and business model.
OGI Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Jul 22, 2025 | ||||
| Follow-on Offering | Jun 18, 2024 | ||||
| Seed | May 30, 2023 | ||||
| Seed | Apr 29, 2022 | ||||
| Pre Seed | Oct 31, 2020 |
Key People
Founding team and executive leadership
OGI Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Sapphire Capital Partners | Seed |
| QUBIS Innovation Fund | Seed |
| Apollo Informal Investment | Seed |
| Old College Capital | Follow-on Offering, Seed |
| Merleview Capital | Seed, Strategic |
OGI Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about OGI Bio's valuation, stock price, and market status.
